Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 08, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --
Aug 08, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Open market or private sale of non-derivative or derivative security 437 $20.96
Jun 25, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 235 $18.76
Jun 25, 2018
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 45,000 --
Jun 18, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 18, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
May 22, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 40,000 $1.47
May 22, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 40,000 --
May 17, 2018
Director
Director Open market or private sale of non-derivative or derivative security 21,113 $18.94
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 112,500 $1.43

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.